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Introduction 
 
Acute kidney injury (AKI) is a major public 
health problem that affects millions of patients 
worldwide and leads to decreased survival and 
increased mortality risk, progression to chronic 
kidney disease, and functional status in daily liv-
ing (1). AKI is the most common cause of organ 
dysfunction in intensive care unit (ICU) patients. 
The incidence of AKI is increasing. Among the 
studies that adopted a Kidney Disease Improving 
Global Outcomes (KDIGO) - equivalent AKI 
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definition, AKI affects 20.9% of patients admit-
ted to the hospital settings and 31.7% of patients 
in critical care settings (2). 
There is no consensus definition of AKI in ICU 
patients. In response to the lack of a standard 
definition for AKI, the Acute Dialysis Quality 
Initiative (ADQI) group developed a consensus 
definition and classification of AKI: the RIFLE 
(Risk, Injury, Failure, Loss of kidney function, 
and End-stage kidney disease) classification sys-
tem (3). The RIFLE classification is based on 
serum creatinine and urine output determinants 
and considers three severity classes of AKI (Risk, 
Injury and Failure), and two outcome classes 
(loss of kidney function and end-stage kidney 
disease). More than two-thirds of all ICU patients 
will develop AKI defined by the RIFLE classifi-
cation. In addition, AKI in ICU patients is asso-
ciated with a prolonged hospital stay, progression 
to chronic kidney disease, and a higher risk of in-
hospital mortality. Increasing RIFLE class is as-
sociated with increasing risk of in-hospital death 
(4). The most important limitation of the RIFLE 
classification is that baseline serum creatinine is 
necessary for the definition and classification of 
AKI. Nevertheless, a more recent classification 
for AKI has been proposed by the Acute Kidney 
Injury Network (AKIN). It reduces the need for 
baseline creatinine but does require at least two 
creatinine values within 48 h (5). 
The RIFLE classification is still commonly used 
as the monitoring of the progression of AKI se-
verity in critically ill patients admitted to ICU and 
has been validated in many research and clinical 
audit purposes. In fact, the AKIN classification 
compared with the RIFLE classification did not 
exhibit a better prognostic acuity in terms of in-
hospital mortality, although it enabled the identi-
fication of more AKI patients (6). 
There have been many studies about the epide-
miology and risk factors of AKI in critically ill 
patients in the different regions of the world and 
most data available are from developed countries 
(7, 8). The incidence and risk factors of AKI in 
developing countries may be different from those 
of developed countries. Therefore, extrapolation 
of results from other countries will not give a val-
id estimate of incidence and risk factors of AKI 
in Iran. Information on overall incidence, risk 
factors and outcome of AKI could help in devel-
oping strategies for prevention and treatment of 
AKI.  
To our knowledge, little data on the incidence 
and risk factors for development of AKI in criti-
cally ill patients are available in Iran, and there-
fore the objective of this prospective study was 
to evaluate the incidence rate, risk factors and 
clinical outcome of AKI using the RIFLE classi-
fication in patients admitted in the ICU. 
 
Materials and Methods 
 
Study Setting  
The study was approved by the Ethics Commit-
tee of the Ardabil University of Medical Sciences 
(Institutional approval Code: IR.AR-
UMS.REC.1394.12). Informed consent was ob-
tained from all individual participants included in 
the study. 
We prospectively performed a study of all ICU 
patients over a period of 12 months from Dec 
2014 to Dec 2015 at Imam Khomeini Hospital, 
Ardabil University of Medical Science, Ardabil, 
Iran. Imam Khomeini Hospital is an educational 
and government institution in southern Iran serv-
ing a population of 1,248,488. With 549 nominal 
bed counts, it provides health care services for all 
of the citizens of north-west of Iran. 
 
Study Population 
All patients who admitted to the ICU with a 
length of stay greater than 48 h were included in 
the study. During the study period, 900 patients 
were admitted to the ICU and the records of all 
patients were reviewed. We excluded patients 
who remained in the ICU for less than 48 h, pa-
tients with a history of chronic kidney disease, 
patients who admitted to the cardiac ICU, and 
those readmitted to the ICU. 
 
Data collection 
A data collection sheet was prepared to summa-
rize the information obtained from each patient 
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record, including the demographic information 
(age, gender, etc.), clinical presentation, cause of 
admission, temperature, smoking, duration of 
hospitalization, patient's condition, the use of 
invasive procedures, respiratory aids, prescription 
antibiotics, pre-existing comorbidities, the possi-
ble causes of AKI, physiological variables and 
laboratory results. In patients discharged alive 
from the hospital, patients were followed up 3 
and 6 months after hospital discharge by tele-
phonic interview. Information on patient survival 
or date of death was obtained from the hospital 
registry office. The primary outcome of the study 
was 3-month and 6-month mortality. 
 
Definitions  
Patients who met any of the criteria of the RI-
FLE classification were defined as AKI patients. 
AKI was considered if there was an increase in 
serum creatinine to more than 1.5-fold of 
baseline value, or a decrease in GFR to more 
than 25% from baseline value, or a urinary out-
put lower than 0.5 mL/kg/h for 6 h. According 
to the status of serum creatinine and urine out-
put, AKI was classified into three categories 
based on severity (Risk, Injury and Failure) and 
two categories based on clinical outcome (Loss 
of kidney function and End-stage kidney disease) 
(3) (Table 1). 
Table 1: The RIFLE classification for acute kidney injury 
 
Classification Serum Creatinine Criteria Urine Output Criteria 
Risk Increase in serum creatinine ≥ 1.5 × baseline or 
decrease in GFR ≥ 25% 
< 0.5 mL/kg per hour × 6 h 
Injury Increase in serum creatinine ≥ 2.0 × baseline or 
decrease in GFR ≥ 50% 
< 0.5 mL/kg per hour × 12 h 
Failure Increase in serum creatinine ≥ 3.0 × baseline or 
serum creatinine ≥ 4.0 mg/dL (354 μmol/L) or 
decrease in GFR ≥ 75% 
< 0.3 mL/kg per hour × 24 h or 
anuria × 12 h 
Loss of kidney function Complete loss of kidney function > 4 wk - 
End-stage kidney disease End stage renal disease (> 3 mo) - 
 
Statistical analysis 
The statistical analysis of the data was done using 
the SPSS software for Windows, version 21 
(SPSS Inc., Chicago, IL, United States). All tests 
were two-sided and results were considered sta-
tistically significant if P-value was less than 0.05. 
Quantitative variables were expressed as means ± 
standard deviation (SD), and qualitative variables 
as percentage. The comparison of the continuous 
variables was accomplished with Student's t or 
Mann-Whitney U tests, and, for the comparison 
of the categorical variables, the Pearson chi-
squared test (χ2 test) and Fisher exact test were 
used. 
The association between development of AKI 
and possible risk factors was initially assessed 
with bivariate analyses (Pearson correlation). The 
potential risk factors were age, sex, smoking sta-
tus, length of hospital stay, blood pressure, 
requirement of mechanical ventilation, relevant 
comorbidities, serum bilirubin, liver enzymes, 
complete blood count (CBC), prescribed drugs, 
and serum concentration of the sodium and po-
tassium. Variables were included in the multivari-
ate analysis if they had a P value of equal to or 
less than 0.20 in the bivariate analysis. The ad-
justed odds ratio (OR) with 95% confidence in-
terval (CI) was calculated by multivariate logistic 
regression analysis. A P-value less than 0.05 was 
considered statistically significant. 
 
Results 
 
Overall, 504 (56%) were men, and 264 (29.3%) of 
the patients had at least one comorbidity. Rele-
vant comorbidities included hypertension (n=47, 
17.8%), pulmonary disease (n=45, 17.1%), cardi-
ovascular disease (n=40, 15.1%), AKI (n=37, 
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14.1%), septic shock (n=28, 10.6%), cerebrovas-
cular accident (n=20, 7.5%), ventilator-associated 
events (n=25, 9.4%), chronic kidney disease 
(n=14, 5.3%), and diabetic ketoacidosis (n=8, 
3.1%). The mean length of hospital stay was 8 ± 
1.2 d. 
 
Incidence of AKI 
The patients were divided into two groups based 
on the RIFLE classification: AKI group consist-
ed 333 (37%; 95% CI, 33.9 to 40.2) patients with 
AKI, and non-AKI group consisted 567 (63%; 
95% CI, 59.8 to 66.1) patients without AKI. The 
AKI group was also classified according to RI-
FLE as follows: Risk (n=74, 8.2%), Injury 
(n=121, 13.4%), Failure (n=119, 13.2%), Loss of 
kidney function (n=12, 1.3%), and End-stage 
kidney disease (n=7, 0.8%). 
 
The relationship between age and sex with 
incidence of AKI 
Overall, the average age of patients was 54.7±8.2 yr 
(ranging from 25-93). Most of the patients (n=396, 
44%) were in the age range 60-80 yr. Among these, 
396 (44%) were women and 504 (56%) were men. 
The average age of the AKI group was 63±5.4 yr, 
and the average age of the non-AKI group was 
45.1±4.9 yr. There was statistically significant dif-
ference between age and the incidence of AKI (P-
value<0.05). Indeed, older age was a risk factor for 
the development of AKI. 
In the patients with AKI, 200 (60.1%) were male 
and 133 (39.9%) were female. In the non-AKI 
group, 304 (53.6%) were male and 263 (46.4%) 
were female. However, no significant relationship 
was found between sex and the incidence of AKI 
(P=0.24) (Table 2). 
 
Table 2: Characteristics of all patients admitted to the ICU (AKI and Non-AKI patients) 
 
Characteristics Total patients 
(n=900) 
Non-AKI patients 
(n=567) 
AKI patients (n=333) P-value 
Mean age (yr) 54.7 ± 8.2 45.1 ± 4.9 63 ± 5.4 <0.05 
Gender Male: 504 (56%) Male: 304 (53.6%) Male: 200 (60.1%)  
 Female: 396 (44%) Female: 263 (46.4%) Female: 133 (39.9%) 0.24 
Smoker 171 (19) 94 (16.8) 77 (23.1) 0.18 
Mortality rate; n (%) 270 (30 ) 76 (13.4 ) 194 (58.3 ) <0.001 
 
The relationship between smoking and 
incidence of AKI 
Of all patients, 171 (19%) were active smokers 
and 729 (81%) were non-smokers. In patients 
with AKI, 77 (23.1%) were active smokers. In the 
non-AKI group, 94 (16.8%) were active smokers. 
However, no significant relationship was found 
between smoking and incidence of AKI 
(P=0.18). 
 
The relationship between laboratory abnor-
malities and incidence of AKI 
Among the 333 patients with AKI, 62.7% had 
anemia, 60% had hyperbilirubinemia, 62.2% had 
increased liver enzymes, 41.8% had sodium dis-
turbances, 38.9% had thrombocytopenia, and 
42.2% had potassium disturbances. There was 
statistically significant difference between anemia, 
hyperbilirubinemia, increased liver enzymes, so-
dium disturbances, and thrombocytopenia with 
the incidence of AKI (P<0.05). However, no sig-
nificant relationship was found between potassi-
um disturbances and the incidence of AKI 
(P=0.48). 
 
Outcome and mortality rate 
The overall mortality among patients studied was 
30% (270/900). The mortality rate was 58.3% 
(194/333) for AKI patients and 13.4% (76/567) 
for non-AKI patients. There was statistically sig-
nificant difference between mortality and the in-
cidence of AKI (P<0.001). 
Based on the RIFLE classification, the mortality 
rate was 37.8% (28/74) for patients with Risk, 
48.8% (59/121) for patients with Injury, 76.5% 
(91/119) for patients with Failure, 83.3% (10/12) 
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for patients with Loss of kidney function, and 
85.7% (6/7) for patients with End-stage kidney 
disease. A significant relationship was found be-
tween the different classes of RIFLE and mor-
tality rate (P<0.0001) (Table 3). 
Out of 194 non-survivors in the AKI group, 111 
(87.2%) died in the hospital, and 83 (42.8%) died 
outside the hospital. In-hospital and out-of-
hospital mortality rate was 71.6% and 28.4%, re-
spectively (Fig. 1). While a significant relationship 
was not found between the different classes of 
RIFLE and short-term mortality (P=0.12), it was 
a significant relationship between the REFLE-F 
class and short-term mortality (P<0.001), so that 
in patients with REFLE-F class, 60-day and 6-
month mortality was 53.8% and 85.7%, respec-
tively, which show a high level of short-term 
mortality in patients with REFLE-F class.
 
Table 3: The outcome of patients by RIFLE classification 
 
Classification Number of patients (%) Mortality rate (%) 
Patients without AKI 567 (63) 13.4 
 
 
Patients with AKI 
Risk 74 (8.2) 37.8 
Injury 121 (13.4) 48.8 
Failure 119 (13.2) 76.5 
Loss of kidney function 12 (1.3) 83.3 
End-stage kidney disease 7 (0.8) 85.7 
 
 
 
Fig. 1: Overall 6-month mortality rate (both in-hospital and out of hospital) for Acute Kidney Injury 
 
Risk factors to the development of AKI 
In the logistic regression analysis, significant risk 
factors for the development of AKI were includ-
ed: age more than 60 yr (P<0.05), length of hos-
pital stay over 6 months (P<0.0001), systolic 
blood pressure less than 100 mmHg (P<0.0001), 
requirement of mechanical ventilation 
(P<0.0001), relevant comorbidities (P=0.006), 
hemoglobin less than 10 g per decilitre (P<0.05), 
platelet count less than 100000 per microliter 
(P<0.05), increased serum bilirubin and liver en-
zymes (P<0.05), and serum sodium abnormalities 
(P<0.05). However, gender (P=0.24), serum po-
tassium abnormalities (P=0.48), and prescribed 
drugs (P=0.18) were not statistically significantly 
associated with the incidence of AKI (Table 4).
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Table 4: Multivariable logistic regression analysis of risk factors of acute kidney injury 
 
Predictor Variable Odds Ratio (95% CI)* P-value 
Age more than 60 yr 1.77 (1.17–2.68) <0.05 
Gender 0.83 (0.39–1.75) 0.244 
Length of hospital stay over 6 months 1.93 (1.31–2.84) <0.0001 
Systolic blood pressure less than 100 mm Hg 2.71 (1.50–4.89) <0.0001 
Requirement of mechanical ventilation 1.20 (0.75–1.91) <0.0001 
Relevant comorbidities 1.27 (0.86–1.86) 0.006 
Anemia 1.70 (0.97–2.90) <0.05 
Thrombocytopenia 1.31 (0.54–3.18) <0.05 
Increased serum bilirubin 1.06 (0.60–1.80) <0.05 
Increased liver enzymes 0.86 (0.43–1.70) <0.05 
Serum sodium abnormalities 1.12 (0.37–3.39) <0.05 
Serum potassium abnormalities 0.88 (0.61–1.26) 0.481 
Prescribed drugs 0.79 (0.59–1.06) 0.183 
*The reference for the odds ratio is the absence of the corresponding risk factor. Variables were entered into the 
multivariable logistic regression model (and, therefore, odds ratios were calculated) when the alpha level of the risk 
factor was less than 0.20 in bivariate analysis 
 
Discussion 
 
This prospective cohort study offers valuable in-
formation for patients admitted to the ICU. First, 
our results confirm the high incidence of AKI in 
the studied population. Hence, the incidence of 
AKI based on the RIFLE classification in ICU 
patients was 37%. Second, although both AKI 
and non-AKI patients were associated with a 
higher mortality in our study, the mortality rate 
was significantly higher in AKI patients (58.3%), 
compared to non-AKI patients (13.4%). Last, our 
study provides significant risk factors for the de-
velopment of AKI. 
Multiple studies have evaluated the incidence, 
risk factors, and outcomes of AKI. For example, 
a meta-analysis of 154 cohort studies, involving 
3,585,911 patients, conducted to estimate the 
world incidence of AKI according to the KDI-
GO staging system. The authors found the inci-
dence rate of AKI to be 21.6% in adults and 
33.7% in children, and a mortality rate of 23.9% 
in adults and 13.8% in children. This meta-
analysis showed reduced mortality rate of AKI-
related during the span of eight yr. In addition, 
the mortality was inversely related to income of 
countries and the percentage of gross domestic 
product spent on total health (2).  
The incidence of AKI in our population was 
higher compared with those reported in Italy 
(10.8%) (9), Australia (11.5%) (10), Finland 
(19.3%) (11), Portugal (50%) (12), and Korea 
(54%) (13), but lower compared with those re-
ported in Japan (73.1%) (14) and USA (67.2%) 
(15). The high mortality in the studied population 
can happen for several reasons. First, we may 
offer poor quality care to our ICU patients. Sec-
ond, the RIFLE classification may need to be 
modified for use in our patients. Third, AKI pa-
tients in our study have a worse prognosis on 
ICU admission. Fourth, the increased sophistica-
tion and managing by more doctor groups may 
have led to this unfavorable outcome via high 
and unnecessary procedures and instrumenta-
tions and overlaps between the managing groups 
originating from a managing discrepancy. Finally, 
the better-equipped centers in other parts of the 
world may have been more aggressive in initiat-
ing dialysis. 
The RIFLE classification is useful for identifying 
patients at greatest risk of adverse short-term 
outcomes. For example, in the United Kingdom, 
in a geographical population base of 523,390, the 
incidence of AKI and acute-on-chronic renal 
failure to be 1811 and 336 cases per million pop-
ulation, respectively (16). In this study, the RI-
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FLE classification was useful for predicting a full 
recovery of renal function (P<0.001), renal re-
placement therapy requirement (P<0.001), length 
of hospital stay (P<0.001), and in-hospital mor-
tality (P=0.035). On the contrary, the RIFLE 
classification might not be associated with mor-
tality in AKI patients in the ICU. For example, a 
study in Republic of Korea investigated 256 geri-
atric patients (≥65 yr old) who developed AKI in 
the ICU according to the RIFLE classification 
(17). In this study, the overall in-hospital mortali-
ty was 39.8 %, and there were no significant dif-
ferences in the RIFLE category between survi-
vors and non-survivors. AKIN versus RIFLE 
classification systems were compared using the 
SAPS 3 database with regard to outcome (18). 
Despite presumed increased sensitivity by the 
AKIN classification, RIFLE shows better ro-
bustness and a higher detection rate of AKI dur-
ing the first 48 h of ICU admission. 
We found that AKI developed in patients older 
than 60 yr of age, length of hospital stay over 6 
months, systolic blood pressure less than 100 
mm Hg, requirement of mechanical ventilation, 
relevant comorbidities, anemia, thrombocytope-
nia, increased serum bilirubin and liver enzymes, 
and serum sodium abnormalities. Independent 
risk factors for mortality of AKI included RIFLE 
class, sepsis, and need for renal replacement ther-
apy, whereas a postsurgical cause of AKI, expo-
sure to nephrotoxins, higher serum creatinine, 
and urine output were associated with lower mor-
tality risk (9). The risk factors for death among 
critically ill patients with AKI were hypotension, 
sepsis, nephrotoxic drug use, respiratory insuffi-
ciency, liver failure, hypovolemia, septic shock, 
multiple organ dysfunction, need for vasoactive 
drugs, need for mechanical ventilation, oliguria, 
hypoalbuminemia, metabolic acidosis and anemia 
(19). In our study, gender, serum potassium, and 
prescribed drugs were not statistically significant 
associated with the incidence of AKI. In contrast, 
age, first serum potassium level, and APACHE II 
score at admission time is powerful independent 
predictors of developing AKI in ICU patients 
(20). 
The present study has several limitations that 
should be considered. First, we specifically fo-
cused on patients admitted to ICU. Second, this 
study was a single-center with a limited sample 
size and these results may not be generalizable to 
other ICUs. Third, as a single-center study, there 
may be bias due to case mix, quality of ICU care, 
ICU policy, and admission criteria. Fourth, this 
study represents a snapshot in time and thus this 
may have led to sampling bias. Finally, we did not 
attempt to compare RIFLE with other classifica-
tion systems. However, data from our study have 
notable similarities and differences in the inci-
dence, risk factor, and outcome of AKI in com-
parison to other different parts of the world. 
 
Conclusion 
 
The RIFLE classification is a useful and suitable 
clinical tool to evaluate the incidence and mortality 
rate of AKI. In ICU patients, AKI is associated 
with increased mortality rate. Further prospective 
and multi-center studies are needed to evaluate the 
incidence and outcomes of AKI in ICU patients. 
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